Clinical Trials on Cardiomyopathies in Australia

Total 48 results

Prof Henry Krum
HD Medical Group Ltd

Terminated

Assessment of Myocardial Disease in Man Using Novel Non-invasive Diagnostic Tools

Cardiovascular Diseases

Australia
The Alfred

Completed

Aspirin Withdrawal in Non-ischaemic Cardiomyopathy Study

Heart Failure

Australia
Flinders University

Recruiting

Role of Perhexiline in Hypertrophic Cardiomyopathy (RESOLVE-HCM)

Hypertrophic Cardiomyopathy

Australia
Flinders University
Flinders Medical Centre; Lyell McEwin Hospital

Recruiting

Assessment of Myocardial Injury in Patients Treated With Immune Checkpoint Inhibitors (MIICI)

Myocardial Injury | Myocarditis | Cardiotoxicity | Immune Checkpoint Inhibitors

Australia
Medical University of Graz
Anniversary Fund of the Oesterreichische Nationalbank

Enrolling by invitation

Cardiac Blood Flow Patterns Associated With Left Ventricular Myocardial Damage (CMR-LHD)

Healthy | Myocardial Injury | Cardiomyopathies

Austria
Thomas Schlöglhofer
Abbott; German Heart Center

Recruiting

Noninvasive Cardiovascular Diagnosis of Patients With Fully Magnetically Levitated Blood Pumps (HM3_Snoopy)

Cardiomyopathies | End-stage Heart Failure | Mechanical Circulatory Support

Austria
MyoKardia, Inc.

Completed

A Single Ascending Dose Study Assessing the Safety, Tolerability, PK and PD of MYK-491

Dilated Cardiomyopathy

Australia
Medical University of Vienna

Completed

Evaluation of Platelet Therapy Response in Left Ventricular Assist Device Patients

Cardiomyopathies | End-stage Heart Failure | Mechanical Circulatory Support

Austria
Vienna Hospital Association

Recruiting

Eccentric Manual Resistance Training in Patients With Ischemic CMP

Ischemic Cardiomyopathy

Austria
Wolfgang Dichtl, MD PhD

Completed

Brain fMRT In Takotsubo Cardiomyopathy (TAKINSULA)

Takotsubo Cardiomyopathy

Austria
Medical University Innsbruck

Completed

Sleep Apnea and CRT Upgrading

Cardiomyopathy

Austria
Medical University of Vienna

Completed

B-type Natriuretic Peptide and Glucose Metabolism

Diabetes Mellitus | Cardiomyopathy

Austria
Liverpool Heart and Chest Hospital NHS Foundation...
Papworth Hospital NHS Foundation Trust

Completed

The SoundScar Study The SOUNDSCAR Study (SoundScar)

Ventricular Tachycardia | Ischemic Cardiomyopathy

Australia, United Kingdom
Medical University of Graz
Medical University Innsbruck

Recruiting

Association Between Lifetime Physical Activity and Exercise and the Development of Wild-type Transthyretin Amyloid Cardiomyopathy

Amyloid Cardiomyopathy | Wild Type ATTR Amyloidosis

Austria
Rennes University Hospital

Recruiting

Effect of Intense Sport Practice in Athletes With Non-ischemic Scar (EISCAR)

Athletes With Isolated Non-ischemic LGE With no Underlying "Labelled" Cardiomyopathy

France, Australia, Belgium, Germany, Luxembourg, United Kingdom
Western Sydney Local Health District

Recruiting

Catheter Ablation Versus Anti-arrhythmic Drugs for Ventricular Tachycardia (CAAD-VT)

Ventricular Tachycardia | Cardiomyopathy, Dilated | Heart Disease Structural Disorder | Sarcoidosis | Cardiomyopathy, Hypertrophic | Cardiomyopathy, Familial | Cardiomyopathy Ischemic | Arrhythmogenic Right Ventricular Cardiomyopathy 1 | Arrhythmogenic Left Ventricular Cardiomyopathy

Australia
Medical University of Graz

Recruiting

Austrian HCM Registry

Hypertrophic Cardiomyopathy

Austria
Ionis Pharmaceuticals, Inc.
AstraZeneca

Recruiting

An Extension Study to Assess Long-Term Safety of Eplontersen in Adults With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)

Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM)

United States, Austria, Belgium, Canada, France, Germany, Israel, Italy, Portugal, Spain, Sweden, United Kingdom, Australia, Greece
Applied Therapeutics, Inc.

Active, not recruiting

Safety and Efficacy of AT-001 in Patients With Diabetic Cardiomyopathy

Diabetic Cardiomyopathies

United States, France, Spain, Australia, Canada, United Kingdom, Germany, Czechia, Hong Kong, Poland
Medical University Innsbruck
Heart and Diabetes Center North Rhine-Westphalia; Austrian Science Fund (FWF)

Recruiting

Liver Disease, Myocardial Fibrosis and Collaterals in the Adult Fontan Patient a Metabolomics and Proteomics Approach

Liver Diseases | Myocardial Fibrosis | Heart Defects, Congenital | Patient Participation | Collateral Circulation, Any Site

Austria
Medical University of Vienna

Recruiting

Post-COVID-19 Outpatient Care and Biomarkers (POSTCOV)

Viral Myocarditis | POTS | Post Viral Fatigue

Austria
Medtronic Cardiac Rhythm and Heart Failure
Medtronic

Completed

PROSPECT: Predictors of Response to Cardiac Re-Synchronization Therapy

Heart Failure | Congestive Heart Failure | Cardiomyopathy

United States, Austria, Belgium, Denmark, Finland, France, Germany, Hong Kong, Italy, Netherlands, Norway, Spain, United Kingdom
University Medical Centre Ljubljana

Recruiting

Conduction System Pacing Versus Biventricular Pacing After Atrioventricular Node Ablation (CONDUCT-AF)

Heart Failure | Atrial Fibrillation | Tachycardia-induced Cardiomyopathy

Croatia, Austria, Belgium, Bulgaria, Romania, Slovenia
LoneStar Heart, Inc.

Completed

A Randomized, Controlled Study to Evaluate Algisyl-LVR™ as a Method of Left Ventricular Augmentation for Heart Failure (AUGMENT-HF)

Heart Failure | Dilated Cardiomyopathy

Italy, Germany, Australia, Netherlands, New Zealand, Romania
King's College London

Completed

International T1 Multicentre CMR Outcome Study (T1-CMR)

Coronary Artery Disease | Fibrosis | Heart Failure | Inflammation | Chronic Kidney Diseases | Cardiomyopathy

United Kingdom, Germany, Australia
Ethicare GmbH

Unknown

Orodispersible Minitablets of Enalapril in Children With Heart Failure Due to Dilated Cardiomyopathy (LENA-WP08)

Heart Failure | Dilated Cardiomyopathy

Austria, United Kingdom, Hungary, Netherlands, Serbia
Ionis Pharmaceuticals, Inc.

Active, not recruiting

CARDIO-TTRansform: A Study to Evaluate the Efficacy and Safety of Eplontersen (Formerly Known as ION-682884, IONIS-TTR-LRx and AKCEA-TTR-LRx) in Participants With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM)

Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM)

United States, Australia, Spain, Canada, Germany, Japan, Italy, Israel, Argentina, France, Portugal, Austria, Brazil, Greece, United Kingdom, Czechia, Sweden, Belgium, Denmark, Poland, Puerto Rico
Eidos Therapeutics, a BridgeBio company

Active, not recruiting

Open-Label Safety Study of Acoramidis (AG10) in Symptomatic ATTR Participants

Amyloid Cardiomyopathy, Transthyretin-Related

United States, Spain, Australia, Canada, Italy, Netherlands, Ireland, New Zealand, Belgium, Israel, Greece, Korea, Republic of, Czechia, Brazil, Denmark, Portugal, United Kingdom
Pfizer

Completed

Long-term Safety of Tafamidis in Subjects With Transthyretin Cardiomyopathy

Transthyretin (TTR) Amyloid Cardiomyopathy

United States, Taiwan, Canada, Belgium, Australia, Czechia, Sweden, Spain, Italy, Hong Kong, Germany, Netherlands, United Kingdom, France, Japan, Argentina, Brazil
Ethicare GmbH

Unknown

Follow-up Safety Trial in Children With Chronic Heart Failure Therapy Receiving Orodispersible Minitablets of Enalapril (LENA-WP10)

Heart Failure | Dilated Cardiomyopathy | Congenital Heart Disease

Austria, United Kingdom, Netherlands, Serbia, Hungary
Pfizer

Completed

Prevalence and Characteristics of Transthyretin Amyloidosis in Patients With Left Ventricular Hypertrophy of Unknown Etiology (TTRACK)

Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)

Italy, Romania, France, Australia, Austria, Portugal, Slovakia, Slovenia, Spain, United Kingdom
Region Skane
Lund University; Uppsala University; Philips Healthcare

Completed

Efficacy of Endovascular Catheter Cooling Combined With Cold Saline for the Treatment of Acute Myocardial Infarction (CHILL-MI)

Myocardial Infarction | Myocardial Reperfusion Injury | Anterior Wall Myocardial Infarction | Inferior Wall Myocardial Infarction

Sweden, Austria, Denmark, Slovenia
Bristol-Myers Squibb

Recruiting

A Study to Evaluate Mavacamten Impact on Myocardial Structure in Participants With Symptomatic Obstructive Hypertrophic Cardiomyopathy (MEMENTO)

Cardiomyopathy, Hypertrophic

United States, Argentina, Australia, Belgium, Canada, Czechia, Hungary, Poland, Switzerland, France, Austria, Finland, Germany, Greece, Italy, Spain
Intellia Therapeutics
Regeneron Pharmaceuticals

Recruiting

MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)

Transthyretin Amyloidosis (ATTR) With Cardiomyopathy

United States, Australia, United Kingdom, New Zealand
Alexion Pharmaceuticals, Inc.

Recruiting

Study of ALXN2220 Versus Placebo in Adults With ATTR-CM (DepleTTR-CM)

Transthyretin Amyloid Cardiomyopathy

United States, Spain, United Kingdom, Norway, Israel, Korea, Republic of, Belgium, France, Germany, Italy, Japan, China, Australia, Argentina, Austria, Taiwan, Switzerland, Canada, Sweden, Poland, Denmark, Turkey, Brazil, Netherlands, G... and more
Sunnybrook Health Sciences Centre
Canadian Institutes of Health Research (CIHR); Weill Medical College of Cornell...

Recruiting

The Canadian CABG or PCI in Patients With Ischemic Cardiomyopathy Trial (STICH3C)

Coronary Artery Disease | Heart Failure Systolic

United States, Canada, Serbia, Poland, Austria, China, Spain, Croatia, India, Italy
Abbott Medical Devices

Completed

Physiologic Pacing Registry

Heart Failure | Heart Block | Bradycardia | Syncope | Cardiomyopathies | Ventricular Tachycardia | Sinus Node Dysfunction

United States, Australia, Netherlands, South Africa, Switzerland, Spain, Germany, Singapore, Canada, Austria, Czechia, France, Hong Kong, India, Italy, Poland
Eidos Therapeutics, a BridgeBio company

Completed

Efficacy and Safety of AG10 in Subjects With Transthyretin Amyloid Cardiomyopathy (ATTRibute-CM)

Heart Diseases | Amyloidosis | Cardiomyopathies | Transthyretin Amyloidosis | Amyloid Cardiomyopathy

United States, Netherlands, Ireland, Canada, Italy, Spain, Belgium, New Zealand, Israel, Australia, Portugal, Brazil, Poland, Czechia, Denmark, Greece, Korea, Republic of, United Kingdom
Bristol-Myers Squibb

Recruiting

A Study of Mavacamten in Non-Obstructive Hypertrophic Cardiomyopathy (ODYSSEY-HCM)

Cardiomyopathy, Hypertrophic

Japan, United States, Spain, Korea, Republic of, Israel, United Kingdom, Norway, Germany, Brazil, Belgium, Hungary, Austria, China, Netherlands, France, Poland, Canada, India, Italy, Portugal, Denmark, Australia, Czechia
Bristol-Myers Squibb

Recruiting

A Study to Evaluate Mavacamten in Adolescents With Symptomatic Obstructive Hypertrophic Cardiomyopathy

Cardiomyopathy, Hypertrophic

United States, Australia, Canada, France, Germany, Ireland, Italy, Spain, United Kingdom
Gilead Sciences

Terminated

Effect of Eleclazine (GS-6615) on Exercise Capacity in Subjects With Symptomatic Hypertrophic Cardiomyopathy (LIBERTY-HCM)

Hypertrophic Cardiomyopathy

Australia, United States, Netherlands, Israel, Italy, France, Germany, United Kingdom
Alnylam Pharmaceuticals

Active, not recruiting

HELIOS-B: A Study to Evaluate Vutrisiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy

Transthyretin Amyloidosis (ATTR) With Cardiomyopathy

United States, Poland, Argentina, Australia, Belgium, France, Germany, Japan, Netherlands, Portugal, Spain, Sweden, United Kingdom, Canada, Czechia, Denmark, Hungary, Ireland, Norway, Korea, Republic of, Austria, Croatia, Israel, Latvia, Lithuan... and more
Yale University
National Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health...

Completed

Exercise in Genetic Cardiovascular Conditions (LIVE-HCM/LQT)

Hypertrophic Cardiomyopathy | Long QT Syndrome

United States, United Kingdom, Canada, Australia, New Zealand
Alnylam Pharmaceuticals

Active, not recruiting

APOLLO-B: A Study to Evaluate Patisiran in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR Amyloidosis With Cardiomyopathy)

Transthyretin Amyloidosis (ATTR) With Cardiomyopathy

United States, Australia, Brazil, Bulgaria, France, Italy, Japan, Mexico, Netherlands, Taiwan, United Kingdom, Belgium, Czechia, Denmark, New Zealand, Sweden, Korea, Republic of, Argentina, Chile, Hong Kong, Portugal
Sanford Health
National Ataxia Foundation; Beyond Batten Disease Foundation; Pitt Hopkins Research... and other collaborators

Recruiting

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford (CoRDS)

Mitochondrial Diseases | Retinitis Pigmentosa | Myasthenia Gravis | Eosinophilic Gastroenteritis | Multiple System Atrophy | Leiomyosarcoma | Leukodystrophy | Anal Fistula | Spinocerebellar Ataxia Type 3 | Friedreich Ataxia | Kennedy Disease | Lyme Disease | Hemophagocytic Lymphohistiocytosis | Spinocerebellar Ataxia... and other conditions

United States, Australia
Children's Oncology Group
National Cancer Institute (NCI)

Recruiting

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

Osteosarcoma | Lymphoblastic Lymphoma | Recurrent Lymphoma | Recurrent Malignant Neoplasm | Hodgkin Lymphoma in Remission | Leukemia in Remission | Recurrent Leukemia

United States, Australia, Canada, Puerto Rico
CENTOGENE GmbH Rostock
Alnylam Pharmaceuticals

Recruiting

TRAMmoniTTR Study Genetic Screening of an At-risk Population for hATTR and Monitoring of TTR Positive Subjects (TRAMmoniTTR)

Cardiomyopathies | Polyneuropathies | Transthyretin Amyloidosis | Transthyretin-Related (ATTR) Familial Amyloid Cardiomyopathy | Transthyretin-Related (ATTR) Familial Amyloid Polyneuropathy

Germany, Austria, Switzerland
LMU Klinikum
University of Pisa; German Federal Ministry of Education and Research; European...

Recruiting

Global Registry and Natural History Study for Mitochondrial Disorders

Mitochondrial Diseases | MDS | Mitochondrial Myopathies | MELAS Syndrome | MIDD | Kearns-Sayre Syndrome | MERRF Syndrome | Barth Syndrome | Leigh Syndrome | MNGIE | LHON | Pearson Syndrome | NARP Syndrome | Coenzyme Q10 Deficiency | SANDO | SCAE | MIRAS | CPEO

Austria, Germany, Italy

Clinical Trials on Cardiomyopathies in Australia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Latvia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations